Effect of Smartphone-Enabled Health Monitoring Devices vs Regular Follow-up on Blood Pressure Control Among Patients After Myocardial Infarction: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Importance: Smart technology via smartphone-compatible devices might improve blood pressure (BP) regulation in patients after myocardial infarction. Objectives: To investigate whether smart technology in clinical practice can improve BP regulation and to evaluate the feasibility of such an intervention. Design, Setting, and Participants: This study was an investigator-initiated, single-center, nonblinded, feasibility, randomized clinical trial conducted at the Department of Cardiology of the Leiden University Medical Center between May 2016 and December 2018. Two hundred patients, who were admitted with either ST-segment elevation myocardial infarction or non-ST-segment acute coronary syndrome, were randomized in a 1:1 fashion between follow-up groups using smart technology and regular care. Statistical analysis was performed from January 2019 to March 2019. Interventions: For patients randomized to regular care, 4 physical outpatient clinic visits were scheduled in the year following the initial event. In the intervention group, patients were given 4 smartphone-compatible devices (weight scale, BP monitor, rhythm monitor, and step counter). In addition, 2 in-person outpatient clinic visits were replaced by electronic visits. Main Outcomes and Measures: The primary outcome was BP control. Secondary outcomes, as a parameter of feasibility, included patient satisfaction (general questionnaire and smart technology-specific questionnaire), measurement adherence, all-cause mortality, and hospitalizations for nonfatal adverse cardiac events. Results: In total, 200 patients (median age, 59.7 years [interquartile range, 52.9-65.6 years]; 156 men [78%]) were included, of whom 100 were randomized to the intervention group and 100 to the control group. After 1 year, 79% of patients in the intervention group had controlled BP vs 76% of patients in the control group (P = .64). General satisfaction with care was the same between groups (mean [SD] scores, 82.6 [14.1] vs 82.0 [15.1]; P = .88). The all-cause mortality rate was 2% in both groups (P > .99). A total of 20 hospitalizations for nonfatal adverse cardiac events occurred (8 in the intervention group and 12 in the control group). Of all patients, 32% sent in measurements each week, with 63% sending data for more than 80% of the weeks they participated in the trial. In the intervention group only, 90.3% of patients were satisfied with the smart technology intervention. Conclusions and Relevance: These findings suggest that smart technology yields similar percentages of patients with regulated BP compared with the standard of care. Such an intervention is feasible in clinical practice and is accepted by patients. More research is mandatory to improve patient selection of such an intervention. Trial Registration: ClinicalTrials.gov Identifier: NCT02976376.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
Defining and measuring patient satisfaction with medical care
Ware, J. E., Snyder, M. K., Wright, W. R., & Davies, A. R. (1983) · Evaluation and Program Planning · doi:10.1016/0149-7189(83)90005-8 · Cited by 1,259
Kraal, J. J., Peek, N., Van den Akker-Van Marle, M. E., & Kemps, H. M. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314552606 · Cited by 116
Cited by
Connected healthcare: Improving patient care using digital health technologies
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J., Elbadawi, M., McCoubrey, L. E., Goyanes, A., Gaisford, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113958 · Cited by 405
Exercise-based cardiac rehabilitation for coronary heart disease
Dibben, G., Faulkner, J., Oldridge, N., Rees, K., Thompson, D. R., Zwisler, A.-D., & Taylor, R. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001800.pub4 · Cited by 354
Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic
Ding, X., Clifton, D., Ji, N., Lovell, N. H., Bonato, P., Chen, W., Yu, X., Xue, Z., Xiang, T., Long, X., et al. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2992838 · Cited by 281
“has investigated the effect of such mHealth technology on managing patients with AMI, and demonstrated feasibility and overall patient acceptance of such smart technology [221].”
BackgroundWearable Devices in Cardiovascular Medicine
Hughes, A., Shandhi, M. M. H., Master, H., Dunn, J., & Brittain, E. (2023) · Circulation Research · doi:10.1161/circresaha.122.322389 · Cited by 291
Wang, Q., Su, M., Zhang, M., & Li, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18116053 · Cited by 277
Jensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab011 · Cited by 93
Self-citationOptimizing telehealth pain care after COVID-19
Tauben, D. J., Langford, D. J., Sturgeon, J. A., Rundell, S. D., Towle, C., Bockman, C., & Nicholas, M. (2020) · Pain · doi:10.1097/j.pain.0000000000002048 · Cited by 75
Cruz-Cobo, C., Bernal-Jiménez, M. Á., Vázquez-García, R., & Santi-Cano, M. J. (2022) · JMIR mHealth and uHealth · doi:10.2196/39593 · Cited by 74
Metadata
- Authors
- Treskes, R. W., van Winden, L. A. M., van Keulen, N., van der Velde, E. T., Beeres, S. L. M. A., Atsma, D. E., & Schalij, M. J.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-04-16
- Volume
- 3
- Issue
- 4
- Pages
- e202165
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3016953591
- Cited by
- 90
- References
- 4
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.